Health ❯ Healthcare ❯ Patient Care ❯ Treatment Options

Innovative Therapies

NICE Endorses Dupilumab as First Targeted Biologic for Uncontrolled Eosinophilic COPD

NHS funding will begin within 90 days of final guidance under strict eligibility plus a 12‑month stop review.

Engineered Antibody From King’s College London Shows Preclinical Promise Against Hard-to-Treat Breast Cancers

Gene Therapy Reports 75% Slower Huntington’s Progression in 36-Month Early Trial

UCLA Details Off-the-Shelf CAR-NKT Therapy With Preclinical Success in Metastatic Kidney Cancer

Zimislecel Therapy Enters Phase 3 After Majority of Type 1 Diabetes Patients Go Insulin-Free

Stem Cell Therapies for Parkinson’s Show Safety and Early Effectiveness in Trials

Novo Nordisk's Obesity Pill Shows Modest Results, Stocks Drop